94 related articles for article (PubMed ID: 22568898)
1. Enhanced antiviral activity of acyclovir loaded into nanoparticles.
Cavalli R; Donalisio M; Bisazza A; Civra A; Ranucci E; Ferruti P; Lembo D
Methods Enzymol; 2012; 509():1-19. PubMed ID: 22568898
[TBL] [Abstract][Full Text] [Related]
2. Enhanced antiviral activity of Acyclovir loaded into beta-cyclodextrin-poly(4-acryloylmorpholine) conjugate nanoparticles.
Cavalli R; Donalisio M; Civra A; Ferruti P; Ranucci E; Trotta F; Lembo D
J Control Release; 2009 Jul; 137(2):116-22. PubMed ID: 19361545
[TBL] [Abstract][Full Text] [Related]
3. Encapsulation of Acyclovir in new carboxylated cyclodextrin-based nanosponges improves the agent's antiviral efficacy.
Lembo D; Swaminathan S; Donalisio M; Civra A; Pastero L; Aquilano D; Vavia P; Trotta F; Cavalli R
Int J Pharm; 2013 Feb; 443(1-2):262-72. PubMed ID: 23279938
[TBL] [Abstract][Full Text] [Related]
4. Preparation and in vitro evaluation of the antiviral activity of the Acyclovir complex of a beta-cyclodextrin/poly(amidoamine) copolymer.
Bencini M; Ranucci E; Ferruti P; Trotta F; Donalisio M; Cornaglia M; Lembo D; Cavalli R
J Control Release; 2008 Feb; 126(1):17-25. PubMed ID: 18079013
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antiherpetic activity of acyclovir phosphonates.
Karpenko IL; Jasko MV; Andronova VL; Ivanov AV; Kukhanova MK; Galegov GA; Skoblov YS
Nucleosides Nucleotides Nucleic Acids; 2003 Mar; 22(3):319-28. PubMed ID: 12816390
[TBL] [Abstract][Full Text] [Related]
6. Factors that affect in vitro measurement of the susceptibility of herpes simplex virus to nucleoside analogues.
Weinberg A; Leary JJ; Sarisky RT; Levin MJ
J Clin Virol; 2007 Feb; 38(2):139-45. PubMed ID: 17169605
[TBL] [Abstract][Full Text] [Related]
7. Self-assembled drug delivery systems. 1. Properties and in vitro/in vivo behavior of acyclovir self-assembled nanoparticles (SAN).
Jin Y; Tong L; Ai P; Li M; Hou X
Int J Pharm; 2006 Feb; 309(1-2):199-207. PubMed ID: 16377106
[TBL] [Abstract][Full Text] [Related]
8. The synergistic effects of betulin with acyclovir against herpes simplex viruses.
Gong Y; Raj KM; Luscombe CA; Gadawski I; Tam T; Chu J; Gibson D; Carlson R; Sacks SL
Antiviral Res; 2004 Nov; 64(2):127-30. PubMed ID: 15498608
[TBL] [Abstract][Full Text] [Related]
9. [Synthesis and antiherpes activity of acyclovir phosphoesters].
Galegov GA; Shobukhov VM; Leont'eva NA; Ias'ko MV
Bioorg Khim; 1997 Nov; 23(11):906-9. PubMed ID: 9518431
[TBL] [Abstract][Full Text] [Related]
10. Macrophage protection against human immunodeficiency virus or herpes simplex virus by red blood cell-mediated delivery of a heterodinucleotide of azidothymidine and acyclovir.
Rossi L; Brandi G; Schiavano GF; Balestra E; Millo E; Scarfi S; Damonte G; Gasparini A; Magnani M; Perno CF; Benatti U; De Flora A
AIDS Res Hum Retroviruses; 1998 Mar; 14(5):435-44. PubMed ID: 9546803
[TBL] [Abstract][Full Text] [Related]
11. Novel nanoparticles made from amphiphilic perfluoroalkyl alpha-cyclodextrin derivatives: preparation, characterization and application to the transport of acyclovir.
Ghera BB; Perret F; Chevalier Y; Parrot-Lopez H
Int J Pharm; 2009 Jun; 375(1-2):155-62. PubMed ID: 19481701
[TBL] [Abstract][Full Text] [Related]
12. Antiviral activity of 2-chloro-2'-deoxyadenosine (2-CdA).
Zahorska R; Mazur N; Skierski JS; Grieb P
Arch Immunol Ther Exp (Warsz); 1996; 44(2-3):137-41. PubMed ID: 8915519
[TBL] [Abstract][Full Text] [Related]
13. Suppression of generation and replication of acyclovir-resistant herpes simplex virus by a sensitive virus.
Okuda T; Kurokawa M; Matsuo K; Honda M; Niimura M; Shiraki K
J Med Virol; 2004 Jan; 72(1):112-20. PubMed ID: 14635018
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and in vitro evaluation of new amphiphilic cyclodextrin-based nanoparticles for the incorporation and controlled release of acyclovir.
Perret F; Duffour M; Chevalier Y; Parrot-Lopez H
Eur J Pharm Biopharm; 2013 Jan; 83(1):25-32. PubMed ID: 23072941
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of amphiphilic beta-cyclodextrin nanoparticles for paclitaxel delivery.
Bilensoy E; Gürkaynak O; Doğan AL; Hincal AA
Int J Pharm; 2008 Jan; 347(1-2):163-70. PubMed ID: 17689901
[TBL] [Abstract][Full Text] [Related]
16. Antiviral activity of the Indian medicinal plant extract Swertia chirata against herpes simplex viruses: a study by in-vitro and molecular approach.
Verma H; Patil PR; Kolhapure RM; Gopalkrishna V
Indian J Med Microbiol; 2008; 26(4):322-6. PubMed ID: 18974483
[TBL] [Abstract][Full Text] [Related]
17. In vitro antiviral activity of distamycin A against clinical isolates of herpes simplex virus 1 and 2 from transplanted patients.
Matteoli B; Bernardini S; Iuliano R; Parenti S; Freer G; Broccolo F; Baggiani A; Subissi A; Arcamone F; Ceccherini-Nelli L
Intervirology; 2008; 51(3):166-72. PubMed ID: 18663321
[TBL] [Abstract][Full Text] [Related]
18. In vitro antiviral activity of Phyllanthus orbicularis extracts against herpes simplex virus type 1.
Fernández Romero JA; Del Barrio Alonso G; Romeu Alvarez B; Gutiérrez Y; Valdés VS; Parra F
Phytother Res; 2003 Sep; 17(8):980-2. PubMed ID: 13680841
[TBL] [Abstract][Full Text] [Related]
19. A new homodimer of aciclovir as a prodrug with increased solubility and antiviral activity.
Brandi G; Rossi L; Schiavano GF; Millo E; Magnani M
Int J Antimicrob Agents; 2009 Aug; 34(2):177-80. PubMed ID: 19394201
[TBL] [Abstract][Full Text] [Related]
20. [Synergistic antiherpetic effect of combined administration of para-aminobenzoic acid and modified nucleosides].
Galegov GA; Akberova SI; Leont'eva NA; Stroeva OG
Biull Eksp Biol Med; 1997 Aug; 124(8):188-91. PubMed ID: 9410207
[No Abstract] [Full Text] [Related]
[Next] [New Search]